Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Homo sapiens | l(3)mbt-like 1 (Drosophila) | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | Lethal(3)malignant brain tumor-like 4 protein, putative | Get druggable targets OG5_130415 | All targets in OG5_130415 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | Get druggable targets OG5_130415 | All targets in OG5_130415 |
Schistosoma japonicum | Lethal(3)malignant brain tumor-like 3 protein, putative | Get druggable targets OG5_130415 | All targets in OG5_130415 |
Schistosoma mansoni | hypothetical protein | Get druggable targets OG5_130415 | All targets in OG5_130415 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | Get druggable targets OG5_130415 | All targets in OG5_130415 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.035 | 0.3601 | 1 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0067 | 0.0111 | 0.0524 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.023 | 0.2122 | 0.2122 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0067 | 0.0111 | 0.0524 |
Loa Loa (eye worm) | inward rectifying k channel family protein 1 | 0.087 | 1 | 1 |
Echinococcus granulosus | histone acetyltransferase MYST2 | 0.0066 | 0.0098 | 0.0462 |
Schistosoma mansoni | myelin transcription factor 1 myt1 | 0.0066 | 0.0098 | 0.0273 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0067 | 0.0111 | 0.0309 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0067 | 0.0111 | 0.0309 |
Echinococcus granulosus | voltage gated potassium channel | 0.0067 | 0.0111 | 0.0524 |
Loa Loa (eye worm) | hypothetical protein | 0.087 | 1 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0251 | 0.2382 | 0.6615 |
Toxoplasma gondii | hypothetical protein | 0.087 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.087 | 1 | 1 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.023 | 0.2122 | 1 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.023 | 0.2122 | 1 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0215 | 0.1936 | 0.5 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.0227 | 0.2085 | 0.9825 |
Echinococcus multilocularis | suppression of tumorigenicity 18 protein | 0.0066 | 0.0098 | 0.0462 |
Loa Loa (eye worm) | hypothetical protein | 0.02 | 0.1748 | 0.1748 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0251 | 0.2382 | 0.6615 |
Loa Loa (eye worm) | MBCTL1 | 0.0066 | 0.0098 | 0.0098 |
Echinococcus granulosus | suppression of tumorigenicity 18 protein | 0.0066 | 0.0098 | 0.0462 |
Loa Loa (eye worm) | hypothetical protein | 0.0067 | 0.0111 | 0.0111 |
Brugia malayi | C2-HC type zinc finger protein C.e-MyT1 | 0.0066 | 0.0098 | 0.0462 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0215 | 0.1936 | 0.5 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.0227 | 0.2085 | 0.9825 |
Onchocerca volvulus | 0.0058 | 0 | 0.5 | |
Onchocerca volvulus | Polycomb protein Sfmbt homolog | 0.0058 | 0 | 0.5 |
Brugia malayi | Voltage-gated potassium channel, EAG (KCNH1)-related. C. elegans egl-2 ortholog | 0.0067 | 0.0111 | 0.0524 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.0098 | 0.0098 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.023 | 0.2122 | 1 |
Echinococcus multilocularis | histone acetyltransferase MYST2 | 0.0066 | 0.0098 | 0.0462 |
Echinococcus multilocularis | voltage gated potassium channel | 0.0067 | 0.0111 | 0.0524 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.5481 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 13.1154 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.9185 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 29.9349 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.